Prof. Dr. Xiaoping Ren | Health Professions | Best Innovation Award

Professor at Lisnom Health, CA, United States

Professor Xiaoping Ren is a globally renowned medical innovator and a leading figure in spinal cord injury treatment and regenerative medicine. As the Chief Scientist of the Global Initiative for the Cure of Paraplegia and Chief Scientific Officer of Lisnom Health, USA, he has pioneered groundbreaking procedures such as the world’s first cephalosomatic anastomosis (head-body transplant) in a mouse model and developed the revolutionary Spinal Cord Fusion (SCF/GEMINI Protocol) using PEG cocktails. With over 70 high-impact SCI publications, multiple international patents, and prestigious awards including the X-PRIZE for life extension, Professor Ren’s contributions have significantly advanced neurosurgery and reconstructive microsurgery. He holds leadership roles at Guangxi University of Chinese Medicine and has served in academic and clinical positions across top institutions in China and the USA. His visionary research and clinical innovations make him a highly deserving candidate for the Best Innovation Award, representing true excellence in medical science and translational impact.

Professional Profile 

• Google Scholar
• Scopus Profile

Education🎓

Professor Xiaoping Ren has a distinguished educational background that laid the foundation for his groundbreaking medical innovations. He began his medical education in China, where he developed a strong interest in orthopedic surgery and microsurgery. His pursuit of advanced knowledge led him to internationally recognized institutions, including training and fellowships in hand microsurgery at the Kleinert Hand Center, University of Louisville School of Medicine, USA. Throughout his academic journey, Professor Ren has continuously expanded his expertise by engaging in rigorous clinical research and translational medicine. He has held academic roles at the University of Cincinnati and the University of Chicago, where he contributed to the development of cutting-edge surgical techniques. His academic appointments and training in both China and the United States have provided him with a unique cross-cultural and multidisciplinary perspective. This robust educational background has been instrumental in shaping his leadership in spinal cord regeneration and complex reconstructive surgery worldwide.

Professional Experience📝

Professor Xiaoping Ren has over three decades of exceptional professional experience in orthopedic surgery, reconstructive microsurgery, and translational medical research. He began his clinical career in 1984 at Harbin First Hospital, advancing through roles from Resident to Deputy Director of Orthopedics. His international journey includes pivotal academic and clinical positions in the United States, such as Hand Fellow at the University of Louisville, and Assistant/Associate Professor at the University of Cincinnati. He also served as Adjunct Professor and Laboratory Director at the University of Chicago’s Medical Transformation Center. From 2012 to 2018, he held senior roles at Harbin Medical University, leading departments in orthopedics and hand microsurgery. Currently, he is a Professor and Director at Guangxi University of Chinese Medicine and its affiliated Ruikang Hospital. Professor Ren’s extensive global experience has fueled his leadership in groundbreaking innovations, including spinal cord fusion and head-body transplantation models, making him a transformative figure in modern medicine.

Research Interest🔎

Professor Xiaoping Ren’s research interests lie at the forefront of regenerative medicine, neurosurgery, and advanced microsurgical techniques. His primary focus is on spinal cord injury repair and functional restoration through innovative approaches such as the Spinal Cord Fusion (SCF/GEMINI Protocol) using PEG-based cocktails. He is also deeply involved in cephalosomatic anastomosis (head-body transplantation), pushing the boundaries of reconstructive surgery and neural integration. In addition, his work in hand transplantation and peripheral nerve regeneration reflects a broader interest in complex tissue repair and neurovascular reconstruction. Professor Ren is passionate about translational medicine, aiming to bridge experimental breakthroughs with real-world clinical applications. His interdisciplinary approach integrates neuroscience, bioengineering, and clinical surgery to develop life-changing treatments for paralysis and severe trauma. Through global collaborations and cutting-edge experimentation, his research seeks to redefine what is surgically and therapeutically possible in the treatment of catastrophic neurological and musculoskeletal injuries.

Award and Honor🏆

Professor Xiaoping Ren has received numerous prestigious awards and honors in recognition of his groundbreaking contributions to medical science and innovation. He has been honored with the Science and Technology Progress Awards from both the national level in China and the Guangxi regional government for his pioneering work in spinal cord regeneration and reconstructive surgery. Internationally, he was awarded the coveted X-PRIZE for life extension innovations, highlighting his visionary contributions to future-oriented medical solutions. Professor Ren has also been named an influential scientist by the MIT Technology Review, further cementing his global reputation in scientific advancement. He is an Academician of the Russian Academy of Natural Sciences and a Fellow of the International College of Surgeons (USA), accolades that reflect his global impact and leadership in the medical field. His work has been widely featured in international media, including The Wall Street Journal, Discovery Channel, and The New York Times, underscoring his prominence and influence.

Research Skill🔬

Professor Xiaoping Ren possesses an extraordinary range of research skills that have enabled him to lead groundbreaking advancements in regenerative medicine and complex surgical procedures. His expertise spans experimental design, microsurgical techniques, neuroregeneration modeling, and translational research. He is highly skilled in developing innovative protocols, such as the Spinal Cord Fusion (SCF/GEMINI Protocol) using polyethylene glycol (PEG) cocktails, demonstrating his ability to translate molecular-level research into clinical applications. Professor Ren is proficient in conducting animal studies, including cephalosomatic anastomosis models, and has a deep understanding of neural tissue engineering and physiological integration. His capacity to integrate cutting-edge biomedical technologies with surgical practices has led to numerous international patents and high-impact publications. Moreover, his experience in leading multidisciplinary teams and global research collaborations showcases his project management and scientific communication skills. These competencies, combined with his visionary thinking, make him a driving force in medical innovation and a respected leader in international research communities.

Conclusion💡

Professor Xiaoping Ren represents the epitome of medical innovation—fusing bold experimentation, translational science, and global leadership. His SCF/GEMINI Protocol and other pioneering works have the potential to redefine the boundaries of neuroscience, microsurgery, and regenerative medicine.

Publications Top Noted✍️

• Ren XP, Wu J, Wang X, Sartor MA, Qian J, Jones K, Nicolaou P, et al.
  2009 – 655 citations
  Title: MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20
  Journal: Circulation 119 (17), 2357–2366

• Wang X, Zhang X, Ren XP, Chen J, Liu H, Yang J, Medvedovic M, Hu Z, et al.
  2010 – 393 citations
  Title: MicroRNA-494 targeting both proapoptotic and antiapoptotic proteins protects against ischemia/reperfusion-induced cardiac injury
  Journal: Circulation 122 (13), 1308–1318

• Diwan A, Krenz M, Syed FM, Wansapura J, Ren X, Koesters AG, Li H, et al.
  2007 – 368 citations
  Title: Inhibition of ischemic cardiomyocyte apoptosis through targeted ablation of Bnip3 restrains postinfarction remodeling in mice
  Journal: The Journal of Clinical Investigation 117 (10), 2825–2833

• Fan GC, Ren X, Qian J, Yuan Q, Nicolaou P, Wang Y, Jones WK, Chu G, et al.
  2005 – 273 citations
  Title: Novel cardioprotective role of a small heat-shock protein, Hsp20, against ischemia/reperfusion injury
  Journal: Circulation 111 (14), 1792–1799

• Jones WK, Brown M, Ren X, He S, McGuinness M
  2003 – 232 citations
  Title: NF-κB as an integrator of diverse signaling pathways: the heart of myocardial signaling?
  Journal: Cardiovascular Toxicology 3, 229–253

• Francois CG, Breidenbach WC, Maldonado C, Kakoulidis TP, Hodges A, et al.
  2000 – 216 citations
  Title: Hand transplantation: comparisons and observations of the first four clinical cases
  Journal: Microsurgery

• Luther KM, Haar L, McGuinness M, Wang Y, Lynch IV TL, Phan A, Song Y, et al.
  2018 – 201 citations
  Title: Exosomal miR-21a-5p mediates cardioprotection by mesenchymal stem cells
  Journal: Journal of Molecular and Cellular Cardiology 119, 125–137

• Fan GC, Zhou X, Wang X, Song G, Qian J, Nicolaou P, Chen G, Ren X, et al.
  2008 – 201 citations
  Title: Heat shock protein 20 interacting with phosphorylated Akt reduces doxorubicin-triggered oxidative stress and cardiotoxicity
  Journal: Circulation Research 103 (11), 1270–1279

• Jones WK, Fan GC, Liao S, Zhang JM, Wang Y, Weintraub NL, et al.
  2009 – 198 citations
  Title: Peripheral nociception associated with surgical incision elicits remote nonischemic cardioprotection via neurogenic activation of protein kinase C signaling
  Journal: Circulation 120 (11_suppl_1), S1–S9

• Wang X, Zhu H, Zhang X, Liu Y, Chen J, Medvedovic M, Li H, Weiss MJ, et al.
  2012 – 166 citations
  Title: Loss of the miR-144/451 cluster impairs ischaemic preconditioning-mediated cardioprotection by targeting Rac-1
  Journal: Cardiovascular Research 94 (2), 379–390

• Jones Jr JW, Üstüner ET, Zdichavsky M, Edelstein J, Ren X, Maldonado C, et al.
  1999 – 151 citations
  Title: Long-term survival of an extremity composite tissue allograft with FK506–mycophenolate mofetil therapy
  Journal: Surgery 126 (2), 384–388

• Qian J, Ren X, Wang X, Zhang P, Jones WK, Molkentin JD, Fan GC, et al.
  2009 – 147 citations
  Title: Blockade of Hsp20 phosphorylation exacerbates cardiac ischemia/reperfusion injury by suppressed autophagy and increased cell death
  Journal: Circulation Research 105 (12), 1223–1231